Exploring Convergence Science Worldwide

 

Convergence thinking & policy

 

 

 

 

 

 

 

Revolutionising Gut Health Monitoring with Miniaturised Biosensors

Aug 11, 2023, 10:04 AM by Arnaud Legrand
A pioneering convergence of genetics, engineering, and electronics has created a miniaturised biosensor. Nitric oxide and hydrogen sulfide, elusive inflammation signals, are detected by engineered probiotic bacteria linked to electronic circuits. This innovation offers real-time insight into gut health, promising early disease detection and personalised care.

 

 

 

In the intricate landscape of our gastrointestinal tract, a complex interplay of molecules governs the delicate balance between health and disease. Among these molecular actors, nitric oxide and hydrogen sulfide stand out as key signals and mediators of inflammation, orchestrating the body's response to various conditions, including inflammatory bowel disease. However, the fleeting nature of these molecules has made their detection a challenge. Now, a convergence of scientific teams has created an innovative solution that could transform how we diagnose and manage gastrointestinal disorders.

 

Imagine a tiny device, smaller than a sugar cube, engineered to capture the presence of these transient molecules within the gut. This cutting-edge technology marries the realms of genetics, engineering, and electronics, offering a powerful tool for real-time monitoring of the biochemical milieu within our intestines.

 

It first begins with genetically modified probiotic bacteria, akin to molecular sentinels, designed to illuminate the presence of inflammation-associated molecules through luminescence. These living sensors provide a dynamic window into the molecular interactions shaping gut health.

 

Then, with the help of the convergence of biological insights and engineering, they created a device that marries probiotic biosensors with sophisticated photodetectors and electronic circuits. This integrated device converts the bioluminescent signals emitted by bacteria into wireless transmissions, enabling seamless communication with external devices.

 

This innovation are is the work of teams from The Koch Institute for Integrative Cancer Research, the Electrical and Computer Engineering Department at Boston University, and MIT Synthetic Biology Center, Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge. Their collaborative efforts have propelled this convergence of disciplines, opening new frontiers in disease diagnosis.

 

This technology not only holds promise for early disease detection but also offers a pathway to personalised healthcare. By continuously monitoring the biochemical environment of the gastrointestinal tract, it paves the way for tailored interventions based on diet, lifestyle, and therapies. With the potential to provide a safer and cost-effective alternative to invasive procedures like endoscopy.

 

M. E. Inda-Webb, M. Jimenez, Q. Liu, N. V. Phan, J. Ahn, C. Steiger, A. Wentworth, A. Riaz, T. Zirtiloglu, K. Wong, K. Ishida, N. Fabian, J. Jenkins, J. Kuosmanen, W. Madani, R. McNally, Y. Lai, A. Hayward, M. Mimee, P. Nadeau, A. P. Chandrakasan, G. Traverso, R. T. Yazicigil & T. K. Lu 

Nature volume 620, pages386–392 (2023)

 

Load more comments
Comment by from

Revolutionising Gut Health Monitoring with Miniaturised Biosensors

Aug 11, 2023, 10:04 AM by Arnaud Legrand
A pioneering convergence of genetics, engineering, and electronics has created a miniaturised biosensor. Nitric oxide and hydrogen sulfide, elusive inflammation signals, are detected by engineered probiotic bacteria linked to electronic circuits. This innovation offers real-time insight into gut health, promising early disease detection and personalised care.

 

 

 

In the intricate landscape of our gastrointestinal tract, a complex interplay of molecules governs the delicate balance between health and disease. Among these molecular actors, nitric oxide and hydrogen sulfide stand out as key signals and mediators of inflammation, orchestrating the body's response to various conditions, including inflammatory bowel disease. However, the fleeting nature of these molecules has made their detection a challenge. Now, a convergence of scientific teams has created an innovative solution that could transform how we diagnose and manage gastrointestinal disorders.

 

Imagine a tiny device, smaller than a sugar cube, engineered to capture the presence of these transient molecules within the gut. This cutting-edge technology marries the realms of genetics, engineering, and electronics, offering a powerful tool for real-time monitoring of the biochemical milieu within our intestines.

 

It first begins with genetically modified probiotic bacteria, akin to molecular sentinels, designed to illuminate the presence of inflammation-associated molecules through luminescence. These living sensors provide a dynamic window into the molecular interactions shaping gut health.

 

Then, with the help of the convergence of biological insights and engineering, they created a device that marries probiotic biosensors with sophisticated photodetectors and electronic circuits. This integrated device converts the bioluminescent signals emitted by bacteria into wireless transmissions, enabling seamless communication with external devices.

 

This innovation are is the work of teams from The Koch Institute for Integrative Cancer Research, the Electrical and Computer Engineering Department at Boston University, and MIT Synthetic Biology Center, Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge. Their collaborative efforts have propelled this convergence of disciplines, opening new frontiers in disease diagnosis.

 

This technology not only holds promise for early disease detection but also offers a pathway to personalised healthcare. By continuously monitoring the biochemical environment of the gastrointestinal tract, it paves the way for tailored interventions based on diet, lifestyle, and therapies. With the potential to provide a safer and cost-effective alternative to invasive procedures like endoscopy.

 

M. E. Inda-Webb, M. Jimenez, Q. Liu, N. V. Phan, J. Ahn, C. Steiger, A. Wentworth, A. Riaz, T. Zirtiloglu, K. Wong, K. Ishida, N. Fabian, J. Jenkins, J. Kuosmanen, W. Madani, R. McNally, Y. Lai, A. Hayward, M. Mimee, P. Nadeau, A. P. Chandrakasan, G. Traverso, R. T. Yazicigil & T. K. Lu 

Nature volume 620, pages386–392 (2023)

 

Load more comments
Comment by from